BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30994337)

  • 1. Differential Recognition of Diet-Derived Neu5Gc-Neoantigens on Glycan Microarrays by Carbohydrate-Specific Pooled Human IgG and IgA Antibodies.
    Leviatan Ben-Arye S; Schneider C; Yu H; Bashir S; Chen X; von Gunten S; Padler-Karavani V
    Bioconjug Chem; 2019 May; 30(5):1565-1574. PubMed ID: 30994337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyclonal human antibodies against glycans bearing red meat-derived non-human sialic acid N-glycolylneuraminic acid are stable, reproducible, complex and vary between individuals: Total antibody levels are associated with colorectal cancer risk.
    Samraj AN; Bertrand KA; Luben R; Khedri Z; Yu H; Nguyen D; Gregg CJ; Diaz SL; Sawyer S; Chen X; Eliassen H; Padler-Karavani V; Wu K; Khaw KT; Willett W; Varki A
    PLoS One; 2018; 13(6):e0197464. PubMed ID: 29912879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling Anti-Neu5Gc IgG in Human Sera with a Sialoglycan Microarray Assay.
    Leviatan Ben-Arye S; Yu H; Chen X; Padler-Karavani V
    J Vis Exp; 2017 Jul; (125):. PubMed ID: 28745644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Neu5Gc carbohydrate and serum antibodies against it provides the molecular link to cancer: French NutriNet-Santé study.
    Bashir S; Fezeu LK; Leviatan Ben-Arye S; Yehuda S; Reuven EM; Szabo de Edelenyi F; Fellah-Hebia I; Le Tourneau T; Imbert-Marcille BM; Drouet EB; Touvier M; Roussel JC; Yu H; Chen X; Hercberg S; Cozzi E; Soulillou JP; Galan P; Padler-Karavani V
    BMC Med; 2020 Sep; 18(1):262. PubMed ID: 32962714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of immunogenic Neu5Gc in bioprosthetic heart valves.
    Reuven EM; Leviatan Ben-Arye S; Marshanski T; Breimer ME; Yu H; Fellah-Hebia I; Roussel JC; Costa C; Galiñanes M; Mañez R; Le Tourneau T; Soulillou JP; Cozzi E; Chen X; Padler-Karavani V
    Xenotransplantation; 2016 Sep; 23(5):381-92. PubMed ID: 27610947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of sialic acids: Implications in xenotransplant biology.
    Paul A; Padler-Karavani V
    Xenotransplantation; 2018 Nov; 25(6):e12424. PubMed ID: 29932472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycan microarray reveal induced IgGs repertoire shift against a dietary carbohydrate in response to rabbit anti-human thymocyte therapy.
    Amon R; Ben-Arye SL; Engler L; Yu H; Lim N; Berre LL; Harris KM; Ehlers MR; Gitelman SE; Chen X; Soulillou JP; Padler-Karavani V
    Oncotarget; 2017 Dec; 8(68):112236-112244. PubMed ID: 29348821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer.
    Padler-Karavani V; Hurtado-Ziola N; Pu M; Yu H; Huang S; Muthana S; Chokhawala HA; Cao H; Secrest P; Friedmann-Morvinski D; Singer O; Ghaderi D; Verma IM; Liu YT; Messer K; Chen X; Varki A; Schwab R
    Cancer Res; 2011 May; 71(9):3352-63. PubMed ID: 21505105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From "Serum Sickness" to "Xenosialitis": Past, Present, and Future Significance of the Non-human Sialic Acid Neu5Gc.
    Dhar C; Sasmal A; Varki A
    Front Immunol; 2019; 10():807. PubMed ID: 31057542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation Mode of Glycans Affect Recognition of Human Serum anti-Neu5Gc IgG Antibodies.
    Bashir S; Leviatan Ben Arye S; Reuven EM; Yu H; Costa C; Galiñanes M; Bottio T; Chen X; Padler-Karavani V
    Bioconjug Chem; 2019 Jan; 30(1):161-168. PubMed ID: 30500162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human species-specific loss of CMP-
    Kawanishi K; Dhar C; Do R; Varki N; Gordts PLSM; Varki A
    Proc Natl Acad Sci U S A; 2019 Aug; 116(32):16036-16045. PubMed ID: 31332008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific Detection of Neu5Gc in Animal Tissues by Immunohistochemistry.
    Paul A; Bachar Abramovitch S; Padler-Karavani V
    Methods Mol Biol; 2020; 2110():59-72. PubMed ID: 32002901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of Neu5Gc and Presence of Anti-Neu5Gc Antibodies in Humans-An Evolutionary Perspective.
    Altman MO; Gagneux P
    Front Immunol; 2019; 10():789. PubMed ID: 31134048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease.
    Padler-Karavani V; Yu H; Cao H; Chokhawala H; Karp F; Varki N; Chen X; Varki A
    Glycobiology; 2008 Oct; 18(10):818-30. PubMed ID: 18669916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Overview of the Importance and Value of Porcine Species in Sialic Acid Research.
    Ogun OJ; Thaller G; Becker D
    Biology (Basel); 2022 Jun; 11(6):. PubMed ID: 35741423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xenogeneic Neu5Gc and self-glycan Neu5Ac epitopes are potential immune targets in MS.
    Boligan KF; Oechtering J; Keller CW; Peschke B; Rieben R; Bovin N; Kappos L; Cummings RD; Kuhle J; von Gunten S; Lünemann JD
    Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 32014849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nontypeable
    Ng PSK; Day CJ; Atack JM; Hartley-Tassell LE; Winter LE; Marshanski T; Padler-Karavani V; Varki A; Barenkamp SJ; Apicella MA; Jennings MP
    mBio; 2019 May; 10(3):. PubMed ID: 31064827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomimetic Glyconanoparticle Vaccine for Cancer Immunotherapy.
    Reuven EM; Leviatan Ben-Arye S; Yu H; Duchi R; Perota A; Conchon S; Bachar Abramovitch S; Soulillou JP; Galli C; Chen X; Padler-Karavani V
    ACS Nano; 2019 Mar; 13(3):2936-2947. PubMed ID: 30840433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative and qualitative changes in anti-Neu5Gc antibody response following rabbit anti-thymocyte IgG induction in kidney allograft recipients.
    Rousse J; Salama A; Leviatan Ben-Arye S; Hruba P; Slatinska J; Evanno G; Duvaux O; Blanchard D; Yu H; Chen X; Bach JM; Padler-Karavani V; Viklicky O; Soulillou JP
    Eur J Clin Invest; 2019 Apr; 49(4):e13069. PubMed ID: 30620396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosylated Biotherapeutics: Immunological Effects of N-Glycolylneuraminic Acid.
    Yehuda S; Padler-Karavani V
    Front Immunol; 2020; 11():21. PubMed ID: 32038661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.